{"id":28032,"date":"2025-05-18T04:45:00","date_gmt":"2025-05-17T20:45:00","guid":{"rendered":"https:\/\/csccm.org.cn\/?p=28032"},"modified":"2025-05-18T06:42:50","modified_gmt":"2025-05-17T22:42:50","slug":"jama-netw-open%e5%8f%91%e8%a1%a8%e8%ae%ba%e6%96%87%ef%bc%9a%e4%bd%8f%e9%99%a2%e6%82%a3%e8%80%85%e7%9a%84%e8%80%90%e8%8d%af%e7%bb%86%e8%8f%8c%e6%84%9f%e6%9f%93","status":"publish","type":"post","link":"https:\/\/csccm.org.cn\/?p=28032","title":{"rendered":"[JAMA Netw Open\u53d1\u8868\u8bba\u6587]\uff1a\u4f4f\u9662\u60a3\u8005\u7684\u8010\u836f\u7ec6\u83cc\u611f\u67d3"},"content":{"rendered":"\n<p>Original Investigation&nbsp;<\/p>\n\n\n\n<p>Infectious Diseases<\/p>\n\n\n\n<p>March&nbsp;14,&nbsp;2025<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Antimicrobial-Resistant Infections in Hospitalized Patients<\/h1>\n\n\n\n<h3 class=\"wp-block-heading\">Hannah&nbsp;Wolford,&nbsp;Natalie L.&nbsp;McCarthy,&nbsp;James&nbsp;Baggs,&nbsp;et al<\/h3>\n\n\n\n<h3 class=\"wp-block-heading\"><em>JAMA Netw Open.&nbsp;<\/em>2025;8(3):e2462059. doi:10.1001\/jamanetworkopen.2024.62059<\/h3>\n\n\n\n<p><a><\/a>Key Points<\/p>\n\n\n\n<p><strong>Question<\/strong>&nbsp;&nbsp;How has antimicrobial resistance changed from 2012 to 2022?<\/p>\n\n\n\n<p><strong>Findings<\/strong>&nbsp;&nbsp;In this cohort study of 7\u202f158\u202f139 cultures from 2012 to 2022, overall resistant cases per 10\u202f000 hospitalizations declined between 2012 to 2016; however, progress varied across pathogens and was inconsistent before the COVID-19 pandemic. The pandemic was associated with notable increases in hospital-onset cases.<\/p>\n\n\n\n<p><strong>Meaning<\/strong>&nbsp;&nbsp;These findings suggest that innovative prevention interventions are needed to reduce antimicrobial resistance, as current interventions may be insufficient.<a><\/a><\/p>\n\n\n\n<p>Abstract<\/p>\n\n\n\n<p><strong>Importance<\/strong>&nbsp;&nbsp;Antimicrobial resistance is a major public health problem in the US. Estimating national rates of antimicrobial-resistant infections commonly associated with health care can aid in targeted public health efforts.<\/p>\n\n\n\n<p><strong>Objective<\/strong>&nbsp;&nbsp;To determine the national incidence rates of 6 pathogens over time: methicillin-resistant&nbsp;<em>Staphylococcus aureus<\/em>&nbsp;(MRSA), vancomycin-resistant&nbsp;<em>Enterococcus<\/em>&nbsp;spp (VRE), extended-spectrum cephalosporin-resistant&nbsp;<em>Escherichia coli<\/em>&nbsp;and&nbsp;<em>Klebsiella<\/em>&nbsp;spp (excluding&nbsp;<em>Klebsiella aerogenes)<\/em>&nbsp;(ESCR-EK), carbapenem-resistant&nbsp;<em>Enterobacterales<\/em>&nbsp;(CRE), carbapenem-resistant&nbsp;<em>Acinetobacter<\/em>&nbsp;spp (CRAsp), and multidrug-resistant (MDR)&nbsp;<em>Pseudomonas aeruginosa<\/em>.<\/p>\n\n\n\n<p><strong>Design, Setting, and Participants<\/strong>&nbsp;&nbsp;This cohort study used data from 2012 to 2022 on inpatient hospitalizations, clinical cultures, and facility-level characteristics. Hospital-months were included in the dynamic cohort if the hospital reported at least 1 culture with microbial growth accompanied by antimicrobial susceptibility testing (AST) results in the month. Data from the PINC-AI and Becton Dickinson Insights databases were used, and cases were defined as incident nonsurveillance cultures yielding an organism of interest with sufficient AST results for a phenotype of interest. Data were collected from January 2012 to December 2022 and analyzed from April 2023 to June 2024.<\/p>\n\n\n\n<p><strong>Exposure<\/strong>&nbsp;&nbsp;Inpatient hospitalizations with a discharge date in an included hospital month.<\/p>\n\n\n\n<p><strong>Main Outcomes and Measures<\/strong>&nbsp;&nbsp;National annual antimicrobial-resistant cases per 10\u202f000 hospitalizations were obtained using weights based on facility-level characteristics. Cases were defined as community-onset if collected on or before day 3 of hospitalization and hospital-onset if obtained on day 4 or later.<\/p>\n\n\n\n<p><strong>Results<\/strong>\u00a0\u00a0This study cohort included 332 to 606 hospitals per year between 2012 to 2022 and 7\u202f158\u202f139 cultures. Antimicrobial-resistant pathogens accounted for an estimated 569\u202f749 (95% CI, 475\u202f949-663\u202f548) cases and 179.6 (95% CI, 163.1-196.1) cases per 10\u202f000 hospitalizations in 2022. Of these cases, 77% (437\u202f657; 95% CI, 364\u202f529-510\u202f785) were community-onset and 23% (132 092; 95% CI, 108\u202f241-155\u202f943) were hospital-onset. MRSA (44% [251\u202f854; 95% CI, 209\u202f558-294\u202f150]) and ESCR-EK (35% [200\u202f884; 95% CI, 163\u202f692-238\u202f077]) made up the largest proportions of total infections in 2022, respectively. Rates of hospital-onset MRSA, VRE, CRE, CRAsp, and MDR\u00a0<em>P aeruginosa<\/em>\u00a0had periods of decline from 2012 to 2019; however, all pathogens experienced an increase in hospital-onset rates in 2020 and 2021. Community-onset ESCR-EK rates increased from 2012 to 2022, while community-onset rates of MRSA, VRE, and MDR\u00a0<em>P aeruginosa<\/em>\u00a0declined.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939562\/zoi241727f1_1741359387.57198.png?Expires=1747827120&amp;Signature=2QXQ5JBeRPGoHibflxXhgj9a0wPh~1OUjfU01GsCmtLDCHrZFSS9qgp-V-fbBkKK8zXsekhs7~k646EQMCx84TNSkt4wALPfs5tEWFt0JZwsjdY8zf0J6YOiCw0LZpQ7-ccdn6NDtwOyKKRN0OlRjsNuuwvonbpfT81hlZyEDNkkwifB1-OQNrVJz8GBEOTkj2mLgOghuHm8lJurZgM1dl7oorK-xK2GlZXam12gdJyRxT7E~~HFWEJJkW9qE~r3qQk7r8-w6HrWOsm9sWFMKXkTQPrAY8aS~jjcymXSzUe6esLjQ8hfOfsrQe9~~v5bz1FcmRXJGP7xwbPIo8IA2A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939562\/zoi241727f2_1741359387.58698.png?Expires=1747827120&amp;Signature=Ji2XcSok21-KrZo6B5~VTEKSjy645MNvqwIo27nDgUvdjdaTV6q06M0gLJFARkGddpg3ybWGIVB5zzfLwec4t6scK6hK-PURm7vsxJQTrDa8CT4P~c~71FgooRAkqKJCYuY38vd0odkiaj4KV~fOWOfYKvPgwIG4~L7zbOpxStFIVbSBXRSGuibxkrXnLGKUABgJbHJwoAOrcuj95RFOCmBJch973EtzppcX3ILdxCMxVxR66nOGPlDoNIh1gfC-e43eoCrkUuPt5HM9ClSGMBS-orvr20fqDrvj0s2nRAIgPUXK6Vw4uaYcdo-WPdxPGu6DM3eIS1Uei4brN31KlQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939562\/zoi241727f3_1741359387.60197.png?Expires=1747827120&amp;Signature=FL5kvo3eRhnzVb0epS8ywEKRng3haPnaXnXZABZJnZRPtkRbL12fxF~X4XdGRxSPN0WXJtJQPBF2YJo~fjCDzSr2AFmEBlbcTkEaHboFw30xZEwMw7T1ek~Ivyoc726f9ZE0RS-vf5VWlYC3xUBUTbw2jslfr2ZqOxIEUWeOJwzjEmiWqkUmDy4kKyeBG0VBQxNrp6j~lwxDM4vrAyDkLmbsBjeWdc730v-s~yZvz7tQIKAqBWr3IP3iuQJxCRq52MPWBN~CsHKV0M3HVfXD6KpYxr9wjtB3RmU3DIROEORqVMsAftrIrGzJ3yP6-xRj82vN7HQcne3kcizkpSQ4Vw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939562\/zoi241727t1_1741359387.51564.png?Expires=1747827120&amp;Signature=nJTRw8MqSghRlp9cSdE8AKBEBTW3X53BB32T01n3U1sw8~IkAbFX0KMgXu-yoN4ZYjHMhmRww7s06tPlBwhyJRTmq2a5Ohs21O0RAMfAKdyqARHa9EwMSTDAGfQS9bKeCxHI4EeSvmy~gL~KxZyhUPlVw11Uk5Gbe2hAKyPYr2ogdaOZdMpeGhpHvNE8O2uAe6utcootFADyqFYmMe3ECl9z9RV0fwZyX0qExJr-UzUbHYOcmNIzuW6e3fOr39p8~MBwIB9lCr~FG2Bfyy83KVgIQTNScbwXoMe0JQjOaOHIhqpYjXKo-~anOMdocDnTnN~oU58oWDjSdJkmT40~hg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.jamanetwork.com\/ama\/content_public\/journal\/jamanetworkopen\/939562\/zoi241727t2_1741359387.53565.png?Expires=1747827120&amp;Signature=Wp32sJ~jTm3jBmPsw6TksdWGRE0pr60diCniZRLqlnWPa3slVSwNLMIieqok~lJmNso-BSTwAHGtwZGnVcINXxLlmGTzqf8gax95c8uotfPyDygqT37BeTllzFIqokJmwUB3gCrC6INMZItqcqhu5Oi~Pyi0vAdMhN9Wzyw7LswQNvQIGahpLAhSDSEuoF5LjhbE5JaehF6lsUaiYJUFFNnuuO6LiHTwRuvpBXzAXA2h3p7anJzkLKPKVnVszkDjLQeLXklGaozz6O53rLThQ31OZkmJwok885YCeGl~qZfwHOZRJj6h4ktpBBc-S-lO1tz3Y3qqXPKlCMaybSn8Tg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"\"\/><\/figure>\n\n\n\n<p><strong>Conclusions and Relevance<\/strong>&nbsp;&nbsp;While antimicrobial resistance rates have experienced uneven declines in the US from 2012 to 2022, the burden of resistance remains substantial. These findings suggest that more effective strategies to reduce antimicrobial resistance are needed.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original Investigation&nbsp; Infectious Diseases March&#038; [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[32,23],"tags":[],"_links":{"self":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/28032"}],"collection":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28032"}],"version-history":[{"count":2,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/28032\/revisions"}],"predecessor-version":[{"id":28261,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=\/wp\/v2\/posts\/28032\/revisions\/28261"}],"wp:attachment":[{"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csccm.org.cn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}